As of January 2026 Intra-Cellular Therapies has a market cap of A$20.91 Billion. This makes Intra-Cellular Therapies the world's 1549th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.